JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
iShares Silver Trust
SLV
$31.3B
| $5.22M | ﹤0.01% |
313,017
+153,593
| +96% | +$2.49M |
|
|
CBB
2527
DELISTED
Cincinnati Bell Inc.
CBB
| $5.21M | ﹤0.01% |
497,739
+149,526
| +43% | +$918K |
|
2528
Scorpio Tankers
STNG
$3.81B
| $5.21M | ﹤0.01% |
132,409
+117,429
| +784% | +$4.02M |
|
|
BCOV
2529
DELISTED
Brightcove, Inc.
BCOV
| $5.21M | ﹤0.01% |
599,137
+38,827
| +7% | +$365K |
|
|
PCH
2530
DELISTED
PotlatchDeltic
PCH
| $5.2M | ﹤0.01% |
120,269
-359,381
| -75% | -$15.3M |
|
2531
Banco Santander
SAN
$211B
| $5.2M | ﹤0.01% |
1,309,916
-2,082,541
| -61% | -$8.09M |
|
2532
CALL
CME Group
CME
$94.3B
| $5.18M | ﹤0.01% |
25,800
| – | – |
|
|
2533
PUT
CME Group
CME
$94.3B
| $5.18M | ﹤0.01% |
25,800
| – | – |
|
2534
FNB Corp
FNB
$6.86B
| $5.18M | ﹤0.01% |
407,752
-364,203
| -47% | -$4.46M |
|
2535
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $5.16M | ﹤0.01% |
257,192
+21,568
| +9% | +$429K |
|
|
GRA
2536
DELISTED
W.R. Grace & Co.
GRA
| $5.16M | ﹤0.01% |
73,873
+26,571
| +56% | +$1.78M |
|
|
AXE
2537
DELISTED
Anixter International Inc
AXE
| $5.16M | ﹤0.01% |
55,985
+2,294
| +4% | +$186K |
|
|
MNTA
2538
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.15M | ﹤0.01% |
260,822
+59,249
| +29% | +$947K |
|
2539
CALL
Humana
HUM
$46.2B
| $5.13M | ﹤0.01% |
14,000
| – | – |
|
|
CNP.PRB
2540
DELISTED
CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S
CNP.PRB
| $5.13M | ﹤0.01% |
105,216
-15,781
| -13% | -$770K |
|
|
OMP
2541
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $5.13M | ﹤0.01% |
308,975
-71,257
| -19% | -$1.19M |
|
2542
Movado Group
MOV
$815M
| $5.11M | ﹤0.01% |
235,173
-103,254
| -31% | -$2.42M |
|
2543
Tandem Diabetes Care
TNDM
$1.63B
| $5.1M | ﹤0.01% |
85,608
-11,447
| -12% | -$706K |
|
2544
CALL
Sony
SONY
$138B
| $5.1M | ﹤0.01% |
375,000
-500
| -0.1% | -$6.23K |
|
|
2545
PUT
Sony
SONY
$138B
| $5.1M | ﹤0.01% |
375,000
| – | – |
|
2546
Visteon
VC
$2.84B
| $5.1M | ﹤0.01% |
58,878
+24,588
| +72% | +$2.19M |
|
2547
CALL
Weibo
WB
$1.91B
| $5.1M | ﹤0.01% |
110,000
| – | – |
|
2548
News Corp Class A
NWSA
$15.5B
| $5.1M | ﹤0.01% |
360,400
-62,983
| -15% | -$848K |
|
2549
NOV
NOV
$7.45B
| $5.09M | ﹤0.01% |
203,108
-2,321
| -1% | -$52.2K |
|
2550
First Community Bankshares
FCBC
$927M
| $5.08M | ﹤0.01% |
163,961
+4,311
| +3% | +$136K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.